How to buy Genpact stock
Learn how to easily invest in Genpact stock.
Genpact is an information technology services business based in the US. Genpact shares (G) are listed on the NYSE and all prices are listed in US Dollars. Genpact employs 121,000 staff and has a trailing 12-month revenue of around $4.4 billion.
How to buy Genpact stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – G. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Genpact stock price (NYSE: G)Use our graph to track the performance of G stocks over time.
Genpact shares at a glance
|Latest market close||$36.68|
|52-week range||$35.18 - $48.21|
|50-day moving average||$37.18|
|200-day moving average||$41.99|
|Wall St. target price||$42.67|
|Dividend yield||$0.525 (1.49%)|
|Earnings per share (TTM)||$2.18|
Buy Genpact stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Genpact stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genpact price performance over time
|1 week (2023-09-15)||-0.81%|
|1 month (2023-08-23)||-0.43%|
|3 months (2023-06-23)||-0.30%|
|6 months (2023-03-21)||-19.28%|
|1 year (2022-09-19)||-19.83%|
|2 years (2021-09-23)||-24.43%|
|3 years (2020-09-23)||37.374|
|5 years (2018-09-21)||22.13%|
Is Genpact stock undervalued or overvalued?
Valuing Genpact stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genpact's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genpact's P/E ratio
Genpact's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Genpact shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Genpact's PEG ratio
Genpact's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Genpact's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Genpact's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $710.1 million.
The EBITDA is a measure of a Genpact's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.4 billion|
|Operating margin TTM||13.62%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||8.32%|
|Return on equity TTM||22.15%|
|Market Capitalization||$6.7 billion|
TTM: trailing 12 months
Genpact share dividends
Dividend payout ratio: 18.86% of net profits
Recently Genpact has paid out, on average, around 18.86% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.49% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genpact shareholders could enjoy a 1.49% return on their shares, in the form of dividend payments. In Genpact's case, that would currently equate to about $0.525 per share.
While Genpact's payout ratio might seem low, this can signify that Genpact is investing more in its future growth.
Genpact's most recent dividend payout was on 25 September 2023. The latest dividend was paid out to all shareholders who bought their shares by 6 September 2023 (the "ex-dividend date").
Genpact share price volatility
Over the last 12 months, Genpact's shares have ranged in value from as little as $35.1802 up to $48.2132. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genpact's is 1.1864. This would suggest that Genpact's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting. It also provides finance and accounting services, which include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. In addition, the company provides supply chain advisory services, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, and master data management; and sales and commercial services, including campaign, order, and dispute management, lead generation, pricing, and promotion optimization. Further, it offers IT services, which comprise end-user computing support, infrastructure management; and transformation services that include digital solutions, consulting services, and analytics services and solutions. The company was founded in 1997 and is based in Hamilton, Bermuda.
Genpact in the news
Reasons Why You Should Retain Genpact (G) in Your Portfolio
Genpact Named a Top Data Science Service Provider for 2023 by Analytics India Magazine (AIM) Research
Zacks Industry Outlook Highlights Automatic Data Processing, Paychex, Broadridge Financial Solutions and Genpact
Frequently asked questionsWhat percentage of Genpact is owned by insiders or institutions?
Currently 0.726% of Genpact shares are held by insiders and 99.816% by institutions. How many people work for Genpact?
Latest data suggests 121,000 work at Genpact. When does the fiscal year end for Genpact?
Genpact's fiscal year ends in December. Where is Genpact based?
Genpact's address is: Canon's, Court, Hamilton, Bermuda, HM 12 What is Genpact's ISIN number?
Genpact's international securities identification number is: USG3922B1073 What is Genpact's CUSIP number?
Genpact's Committee on Uniform Securities Identification Procedures number is: G3922B107
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert